Myeloid-Mas Signaling Modulates Pathogenic Crosstalk among MYC+CD63+ Endothelial Cells, MMP12+ Macrophages, and Monocytes in Acetaminophen-Induced Liver Injury

#DAPI (Hydrochloride) ; # 2879038 ; 

**** BioGems 제품이나 Peprotech 으로 표기

Adv Sci (Weinh). 2024 Apr;11(16):e2306066.

Shuai Chen ¹, Zhi Lu ^2 3, Yudong Zhao ⁴, Lu Xia ¹, Chun Liu ¹, Siqing Zuo ^2 3, Manchang Jin ^3 5, Haoyu Jia ¹, Shanshan Li ¹, Shuo Zhang ¹, Bo Yang ¹, Zhijing Wang ¹, Jing Li ¹, Fei Wang ⁶, Changqing Yang ¹

Affiliations expand

• PMID: 38350725
• PMCID: PMC11040347
• DOI: 10.1002/advs.202306066

Abstract

Acetaminophen overdose is a leading cause of acute liver failure (ALF). Despite the pivotal role of the inflammatory microenvironment in the progression of advanced acetaminophen-induced liver injury (AILI), a comprehensive understanding of the underlying cellular interactions and molecular mechanisms remains elusive. Mas is a G protein-coupled receptor highly expressed by myeloid cells; however, its role in the AILI microenvironment remains to be elucidated. A multidimensional approach, including single-cell RNA sequencing, spatial transcriptomics, and hour-long intravital imaging, is employed to characterize the microenvironment in Mas1 deficient mice at the systemic and cell-specific levels. The characteristic landscape of mouse AILI models involves reciprocal cellular communication among MYC⁺CD63⁺ endothelial cells, MMP12⁺ macrophages, and monocytes, which is maintained by enhanced glycolysis and the NF-κB/TNF-α signaling pathway due to myeloid-Mas deficiency. Importantly, the pathogenic microenvironment is delineated in samples obtained from patients with ALF, demonstrating its clinical relevance. In summary, these findings greatly enhance the understanding of the microenvironment in advanced AILI and offer potential avenues for patient stratification and identification of novel therapeutic targets.